Citius Pharmaceuticals, Inc. Sale of Stock, Consideration Received Per Transaction
Citius Pharmaceuticals, Inc. (CTXR) reported Sale of Stock, Consideration Received Per Transaction of $657.28 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. sale of stock, consideration received per transaction for the quarter ending 2025-09-30 was $657.28K.
- Citius Pharmaceuticals, Inc. sale of stock, consideration received per transaction for the quarter ending 2025-06-30 was $3.47M.
| Period end | Sale of Stock, Consideration Received Per Transaction 3 month | Sale of Stock, Consideration Received Per Transaction 6 month |
|---|---|---|
| 2025-09-30 | $657.28K 10-Q · filed 2026-08-14 | $4.13M derived: sum of 2 quarters · filed 2026-08-14 |
| 2025-06-30 | $3.47M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |